Big Pharma Hurts Maternal Health
Giving birth in America is nearly twice as deadly as doing so in Europe. Big Pharma is partly responsible, choking the 3...
18 September, 2023340B Matters seeks to protect this vital drug discount program for nonprofit healthcare facilities. We support patients over profits. Learn More
Giving birth in America is nearly twice as deadly as doing so in Europe. Big Pharma is partly responsible, choking the 3...
18 September, 2023In recent years, drug companies have regularly touted the need for more information from hospitals participating in the ...
17 July, 2023Leading hospital trade groups recently announced they are willing to seek a legislative solution to update the 340B Drug...
29 May, 2023The Winter 340B Coalition conference was more like “Spring” from a timing perspective, and we associate springtime with ...
03 April, 2023As the healthcare landscape is changing, 340B is at risk. The total direct and indirect funding hospitals will lose if the discounts are reduced is unknown. Learn More
Virtually all communities in the U.S. benefit from providers that participate in 340B. Learn More
Dozens of hospitals and clinics will close without the 340B drug discount program, especially in rural areas. Safety-net hospitals will have to reduce services for vulnerable patients. Learn More